View up-to-date information on Allogene Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2022187663A1 | Application | FASL EXPRESSION AND FASR GENE KNOCKOUT TO PROTECT THERAPEUTIC CELLS FROM ALLOGENEIC REJECTION AND ACTIVATION-INDUCED CELL DEATH | A61K35/17; A61P35/00; A61P37/00; A61P37/06; C07K14/7051; C07K14/70575; C07K14/70578; C07K2319/03; C12N15/11; C12N15/86; C12N15/907; C12N2310/20; C12N2501/599; C12N2510/00; C12N2740/15043; C12N2800/80; C12N5/0636; C12N9/22; Y02A50/30 | September 09, 2022 |
| US20220281950A1 | Application | FASL EXPRESSION AND FASR GENE KNOCKOUT TO PROTECT THERAPEUTIC CELLS FROM ALLOGENEIC REJECTION AND ACTIVATION-INDUCED CELL DEATH | A61K35/17; A61P37/06; C07K14/70575; C12N15/11; C12N15/86; C12N15/907; C12N2310/20; C12N2510/00; C12N2740/15043; C12N2800/80; C12N5/0636; C12N9/22 | September 08, 2022 |
| CO2022011684A2 | Application | Células t con car de bcma con actividades mejoradas | A61K2039/5156; A61K35/17; A61K38/00; A61K39/0011; A61P35/00; A61P35/02; C07K14/7051; C07K14/70578; C07K14/715; C07K14/7151; C07K14/7155; C07K16/2878; C07K2317/622; C07K2319/03; C07K2319/33; C12N15/86; C12N2510/00; C12N5/0636 | August 30, 2022 |
| AU2021227191A1 | Application | BCMA car-T cells with enhanced activities | A61K2039/5156; A61K35/17; A61K38/00; A61K39/0011; A61P35/00; A61P35/02; C07K14/7051; C07K14/70578; C07K14/715; C07K14/7151; C07K14/7155; C07K16/2878; C07K2317/622; C07K2319/03; C07K2319/33; C12N15/86; C12N2510/00; C12N5/0636 | August 25, 2022 |
| EP4041454A1 | Application | KUNSTSTOFFHÜLLE FÜR FLÄSCHCHENETIKETTIERSYSTEME | A01N1/0268; A61J1/1468; A61J1/165; A61J2205/30; B01L2300/021; B01L2300/0854; B01L3/5453; B65D23/005; B65D23/0857; B65D23/0885 | August 17, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer